Literature DB >> 34123569

Can Dermoscopy Be Used to Predict if a Melanoma Is In Situ or Invasive?

Sam Polesie1,2, Edvin Jergéus1, Martin Gillstedt1,2, Hannah Ceder1,2, Johan Dahlén Gyllencreutz1, Julia Fougelberg1,2, Eva Johansson Backman1,2, Jenna Pakka1,2, Oscar Zaar1,2, John Paoli1,2.   

Abstract

BACKGROUND: The preoperative prediction of whether melanomas are invasive or in situ can influence initial management.
OBJECTIVES: This study evaluated the accuracy rate, interobserver concordance, sensitivity and specificity in determining if a melanoma is invasive or in situ, as well as the ability to predict invasive melanoma thickness based on clinical and dermoscopic images.
METHODS: In this retrospective, single-center investigation, 7 dermatologists independently reviewed clinical and dermoscopic images of melanomas to predict if they were invasive or in situ and, if invasive, their Breslow thickness. Fleiss' and Cohen's kappa (κ) were used for interobserver concordance and agreement with histopathological diagnosis.
RESULTS: We included 184 melanomas (110 invasive and 74 in situ). Diagnostic accuracy ranged from 67.4% to 76.1%. Accuracy rates for in situ and invasive melanomas were 57.5% (95% confidence interval [CI], 53.1%-61.8%) and 81.7% (95% CI, 78.8%-84.4%), respectively. Interobserver concordance was moderate (κ = 0.47; 95% CI, 0.44-0.51). Sensitivity for predicting invasiveness ranged from 63.6% to 91.8% for 7 observers, while specificity was 32.4%-82.4%. For all correctly predicted invasive melanomas, agreement between predictions and correct thickness over or under 1.0 mm was moderate (κ = 0.52; 95% CI, 0.45-0.58). All invasive melanomas incorrectly predicted by any observer as in situ had a thickness <1.0 mm. All 32 melanomas >1.0 mm were correctly predicted to be invasive by all observers.
CONCLUSIONS: Accuracy rates for predicting thick melanomas were excellent, melanomas inaccurately predicted as in situ were all thin, and interobserver concordance for predicting in situ or invasive melanomas was moderate. Preoperative dermoscopy of suspected melanomas is recommended for choosing appropriate surgical margins. ©2021 Polesie et al.

Entities:  

Keywords:  Breslow thickness; Dermoscopy; Inter Observer Variability; Melanoma; Projections and Predictions

Year:  2021        PMID: 34123569      PMCID: PMC8172039          DOI: 10.5826/dpc.1103a79

Source DB:  PubMed          Journal:  Dermatol Pract Concept        ISSN: 2160-9381


  16 in total

1.  Pre-operative diagnosis of pigmented skin lesions: in vivo dermoscopy performs better than dermoscopy on photographic images.

Authors:  P Carli; V De Giorgi; G Argenziano; D Palli; B Giannotti
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-07       Impact factor: 6.166

2.  Dermoscopic features of thin melanomas: a comparative study of melanoma in situ and invasive melanomas smaller than or equal to 1mm.

Authors:  Vanessa Priscilla Martins da Silva; Juliana Kida Ikino; Mariana Mazzochi Sens; Daniel Holthausen Nunes; Gabriella Di Giunta
Journal:  An Bras Dermatol       Date:  2013 Sep-Oct       Impact factor: 1.896

3.  Meta-analysis of number needed to treat for diagnosis of melanoma by clinical setting.

Authors:  Amy J Petty; Bradley Ackerson; Reed Garza; Michael Peterson; Beiyu Liu; Cynthia Green; Michelle Pavlis
Journal:  J Am Acad Dermatol       Date:  2020-01-11       Impact factor: 11.527

4.  Dermoscopic criteria for melanoma in situ are similar to those for early invasive melanoma.

Authors:  M A Pizzichetta; G Argenziano; R Talamini; D Piccolo; A Gatti; G Trevisan; G Sasso; A Veronesi; A Carbone; H P Soyer
Journal:  Cancer       Date:  2001-03-01       Impact factor: 6.860

5.  Preoperative assessment of melanoma thickness by ABCD score of dermatoscopy.

Authors:  P Carli; V de Giorgi; D Palli; V Giannotti; B Giannotti
Journal:  J Am Acad Dermatol       Date:  2000-09       Impact factor: 11.527

6.  Trends in incidence of thick, thin and in situ melanoma in Europe.

Authors:  L Sacchetto; R Zanetti; H Comber; C Bouchardy; D H Brewster; P Broganelli; M D Chirlaque; D Coza; J Galceran; A Gavin; M Hackl; A Katalinic; S Larønningen; M W J Louwman; E Morgan; T E Robsahm; M J Sanchez; L Tryggvadóttir; R Tumino; E Van Eycken; S Vernon; V Zadnik; S Rosso
Journal:  Eur J Cancer       Date:  2018-01-31       Impact factor: 9.162

7.  A retrospective study comparing the accuracy of prehistology diagnosis and surgical excision of malignant melanomas by general practitioners and hospital specialists.

Authors:  M Bakhai; D Hopster; R Wakeel
Journal:  Clin Exp Dermatol       Date:  2009-09-23       Impact factor: 3.470

8.  Dermoscopy compared with naked eye examination for the diagnosis of primary melanoma: a meta-analysis of studies performed in a clinical setting.

Authors:  M E Vestergaard; P Macaskill; P E Holt; S W Menzies
Journal:  Br J Dermatol       Date:  2008-07-04       Impact factor: 9.302

9.  Clinical and dermatoscopic criteria for the preoperative evaluation of cutaneous melanoma thickness.

Authors:  G Argenziano; G Fabbrocini; P Carli; V De Giorgi; M Delfino
Journal:  J Am Acad Dermatol       Date:  1999-01       Impact factor: 11.527

10.  European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019.

Authors:  Claus Garbe; Teresa Amaral; Ketty Peris; Axel Hauschild; Petr Arenberger; Lars Bastholt; Veronique Bataille; Veronique Del Marmol; Brigitte Dréno; Maria Concetta Fargnoli; Jean-Jacques Grob; Christoph Höller; Roland Kaufmann; Aimilios Lallas; Celeste Lebbé; Josep Malvehy; Mark Middleton; David Moreno-Ramirez; Giovanni Pellacani; Philippe Saiag; Alexander J Stratigos; Ricardo Vieira; Iris Zalaudek; Alexander M M Eggermont
Journal:  Eur J Cancer       Date:  2019-12-19       Impact factor: 9.162

View more
  1 in total

1.  Multispectral Imaging Algorithm Predicts Breslow Thickness of Melanoma.

Authors:  Szabolcs Bozsányi; Noémi Nóra Varga; Klára Farkas; András Bánvölgyi; Kende Lőrincz; Ilze Lihacova; Alexey Lihachev; Emilija Vija Plorina; Áron Bartha; Antal Jobbágy; Enikő Kuroli; György Paragh; Péter Holló; Márta Medvecz; Norbert Kiss; Norbert M Wikonkál
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.